ANIX · Insider Trading
Anixa Biosciences, Inc.
Every open-market purchase and sale reported by ANIX officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-30 | Michael Catelani | President, COO, & CFO | Buy | +5,500 | +$15.62K |
| 2026-09-28 | Arnold M Baskies | Director | Buy | +5,000 | +$13.80K |
| 2026-09-28 | Amit Kumar | Chief Executive Officer | Buy | +7,000 | +$19.46K |
| 2026-09-25 | Lewis H Titterton jr | Director | Buy | +49,036 | +$131.91K |
| 2026-09-14 | Amit Kumar | Chief Executive Officer | Buy | +3,000 | +$8.25K |
| 2026-09-14 | Lewis H Titterton jr | Director | Buy | +10,000 | +$27.30K |
| 2026-09-11 | Amit Kumar | Chief Executive Officer | Buy | +5,000 | +$13.80K |
| 2026-08-03 | Amit Kumar | Chief Executive Officer | Buy | +5,000 | +$17.35K |
| 2026-07-29 | Arnold M Baskies | Director | MIXED | +572 | −$1 |
| 2026-07-28 | Amit Kumar | Chief Executive Officer | Buy | +5,000 | +$17.20K |
| 2026-07-27 | Amit Kumar | Chief Executive Officer | Buy | +3,188 | +$10.74K |
| 2026-07-27 | Amit Kumar | Chief Executive Officer | Buy | +3,000 | +$11.19K |
| 2026-07-21 | Amit Kumar | Chief Executive Officer | Buy | +5,000 | +$17.30K |
| 2026-07-20 | Lewis H Titterton jr | Director | Buy | +12,000 | +$41.64K |
| 2026-07-16 | Lewis H Titterton jr | Director | Buy | +2,797 | +$9.17K |
| 2026-07-13 | Amit Kumar | Chief Executive Officer | Buy | +5,000 | +$15.20K |
| 2026-06-17 | Lewis H Titterton jr | Director | Buy | +2,836 | +$7.49K |
| 2026-06-16 | Amit Kumar | Chief Executive Officer | Buy | +21,000 | +$52.50K |
| 2026-01-29 | Arnold M Baskies | Director | Buy | +10,000 | +$30.40K |
| 2026-01-06 | Emily Gottschalk | Director | A | +25,000 deriv. | — |
| 2026-01-06 | Amit Kumar | Chief Executive Officer | A | +350,000 deriv. | — |
| 2026-01-06 | Lewis H Titterton jr | Director | A | +25,000 deriv. | — |
| 2026-01-06 | Michael Catelani | President, COO & CFO | A | +175,000 deriv. | — |
| 2026-01-06 | Arnold M Baskies | Director | A | +25,000 deriv. | — |
| 2025-12-16 | Lewis H Titterton jr | Director | M | +16,000 | +$46.72K |
| 2025-10-31 | Amit Kumar | Chief Executive Officer | MIXED | +30,561 | −$103.92K |
| 2025-08-04 | Lewis H Titterton jr | Director | Buy | +10,000 | +$30.80K |
| 2025-07-31 | Amit Kumar | Chief Executive Officer | Buy | +5,000 | +$15.80K |
| 2025-07-21 | Arnold M Baskies | Director | Buy | +5,000 | +$16.95K |
| 2025-07-15 | Lewis H Titterton jr | Director | Buy | +10,000 | +$31.40K |
| 2025-07-14 | Amit Kumar | Chief Executive Officer | Buy | +5,000 | +$15.75K |
| 2025-06-05 | Amit Kumar | Chief Executive Officer | Buy | +10,000 | +$28.50K |
| 2025-01-29 | Arnold M Baskies | Director | Buy | +5,000 | +$14.10K |
| 2025-01-27 | Lewis H Titterton jr | Director | Buy | +3,000 | +$8.82K |
| 2025-01-23 | Lewis H Titterton jr | Director | Buy | +2,000 | +$6.02K |
| 2025-01-22 | Lewis H Titterton jr | Director | Buy | +6,000 | +$15.54K |
| 2025-01-17 | Lewis H Titterton jr | Director | Buy | +10,000 | +$25.70K |
| 2025-01-15 | Michael Catelani | President, COO, & CFO | Buy | +9,289 | +$19.97K |
| 2025-01-15 | Amit Kumar | Chief Executive Officer | Buy | +43,000 | +$95.89K |
| 2025-01-03 | Lewis H Titterton jr | Director | A | +25,000 deriv. | — |
| 2025-01-03 | Arnold M Baskies | Director | A | +25,000 deriv. | — |
| 2025-01-03 | Emily Gottschalk | Director | A | +25,000 deriv. | — |
| 2025-01-03 | Amit Kumar | Chief Executive Officer | A | +700,000 deriv. | — |
| 2025-01-03 | Michael Catelani | President, COO & CFO | A | +350,000 deriv. | — |
| 2024-10-23 | Lewis H Titterton jr | Director | M | +16,000 | +$41.20K |
| 2024-08-01 | Lewis H Titterton jr | Director | Buy | +27,226 | +$84.26K |
| 2024-07-29 | Lewis H Titterton jr | Director | Buy | +8,496 | +$25.57K |
| 2024-07-26 | Arnold M Baskies | Director | Buy | +5,000 | +$15.45K |
| 2024-06-18 | Lewis H Titterton jr | Director | Buy | +4,000 | +$10.72K |
| 2024-06-14 | Lewis H Titterton jr | Director | Buy | +405 | +$1.09K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Lewis H Titterton jr | Director | 1,046,003 | $3.03M |
| Amit Kumar | Chief Executive Officer | 672,000 | $1.95M |
| Arnold M Baskies | Director | 140,572 | $407.66K |
| Michael Catelani | President, COO, & CFO | 50,000 | $145.00K |
| Emily Gottschalk | Director | 45,665 | $132.43K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ANIX quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.